
Targeted Therapies in Oncology
- September I 2025
- Volume 14
- Issue 11
6 Must-Have AI Features in Practice Management
Key Takeaways
- AI tools can automate SOAP note transcription and appointment scheduling, improving efficiency and patient experiences.
- Not all AI solutions are equally effective; some depend on templates and manual input, while others offer true automation.
Discover how AI transforms practice management by streamlining documentation, enhancing patient experiences, and optimizing workflows for healthcare professionals.
Clinicians are under increasing pressure to see more patients, handle complex care needs, and stay compliant with ever‑changing regulations—all while managing mountains of documentation and administrative tasks. Artificial intelligence (AI) offers tools that can reduce that burden.
From automatically transcribing subjective, objective, assessment, and plan (SOAP) notes during patient visits to optimizing appointment schedules, AI‑enabled software now delivers measurable time savings, fewer errors, and better patient experiences.
The challenge is that dozens of solutions claim to have “AI‑powered” features, but not all are created equal. Some platforms rely heavily on templates and manual input, while others truly automate tasks that used to take hours.
To help you understand what’s possible, here are 6 AI features that practices use successfully daily. These capabilities can transform how you manage your electronic health records (EHRs), patient scheduling, and telehealth workflows. For more information visit:
Articles in this issue
about 2 months ago
ADG126 Exhibits Clinical Meaningful Efficacy in MSS CRCabout 2 months ago
Novel Bispecific Yields Safety, Activity Across Tumor Typesabout 2 months ago
KIM-1 Emerges as Potential Biomarker in Renal Cell Carcinomaabout 2 months ago
Belzutifan Extends Quality-Adjusted Survival Time in Advanced RCCabout 2 months ago
Casdatifan/Cabozantinib Shows Efficacy in Pretreated ccRCCabout 2 months ago
Tumor-Associated Macrophages May Improve Outcomes in Metastatic RCCabout 2 months ago
Pembrolizumab Plus Lenvatinib Delivers in nccRCCabout 2 months ago
Factors Supporting TKI Discontinuation in Ph+ ALL







































